Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
| Description | Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) |
| BNF code | 0601012V0BDACAD |
| Virtual Medicinal Product | Insulin glargine 100units/ml solution for injection 3ml pre-filled disposable devices |
| Name | Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens |
| Abbreviated name | Abasaglar KwikPen 100units/ml inj 3ml pre-filled pens |
| Date of name applicability | 27 Feb 2020 |
| Previous name | Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pen |
| Supplier | Eli Lilly and Company Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Subcutaneous |
| Actual Medicinal Product Packs | |
| Abasaglar KwikPen 100units/ml solution for injection 3ml pre-filled pens (Eli Lilly and Company Ltd) 5 pre-filled disposable injection | |
dm+d data retrieved from TRUD: release NHSBSA_5.1.0_20240513000001, imported on 13th May 2024 at 05:02:36.